XOMA Royalty Corporation

Healthcare · Biotechnology · United States

Last price 40.17 USD (At close: Jul 13, 2026) · Market cap 710.16M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets ...